pure scientific

PURE SCIENTIFIC
TECHNOLOGIES INC.

Developing new patent-pending drug delivery systems

PURE SCIENTIFIC
TECHNOLOGIES INC.

DEVELOPING NEW PATENT-PENDING
DRUG DELIVERY SYSTEM

PURE SCIENTIFIC
TECHNOLOGIES INC.

DEVELOPING NEW PATENT-PENDING
DRUG DELIVERY SYSTEM

pure scientificpure scientific

OUR MISSION

To develop and market innovative products
based on our patented technology utilizing
the unique inhalation delivery dynamics of
pharmaceuticals to improve treatment,
outcomes, and quality of life.

OUR MISSION

To develop and market innovative
products based on its patent-pending
technologies utilizing Heliox and
other gases for needle-free delivery
of pharmaceuticals and CBD
directly into the lungs.

OUR MISSION

To develop and market innovative
products based on its patent-pending
technologies utilizing Heliox and
other gases for needle-free delivery
of pharmaceuticals and CBD
directly into the lungs.

PST HELIOX INHALERPST HELIOX INHALER

“striving to make medicine work better for you….”

Our focus is to optimize drug delivery to specific
regions of the lung by utilizing the dynamic flow
of heliox and other carrier gases to treat a
broad range of pulmonary diseases.

PST HELIOX INHALER

“striving to make medicine
work better for you….”

Leveraging Helox as a Carrier Gas,
our aim is to maximize benefits of drugs
used to treat diseases such as lung cancer,
chronic bronchitis, asthma and other
obstructive pulmonary conditions.

PST HELIOX INHALER

“striving to make medicine
work better for you….”

Leveraging Helox as a Carrier Gas,
our aim is to maximize benefits of drugs
used to treat diseases such as lung cancer,
chronic bronchitis, asthma and other
obstructive pulmonary conditions.

Growing inhalable drug Market

Estimated to reach $65.4B by 2034.

20+ Years Experience

Our team of executives has the experience and commitment that it takes to bring medical products to market.

a unique DELIVERY system

The “HELIOS” inhalation system offers targeted drug delivery with the potential to reduce negative side effects.

MISSION

To develop and market innovative products based on our patented technology utilizing the unique inhalation delivery dynamics of pharmaceuticals to improve treatment, outcomes, and quality of life.

TECHNOLOGY UTILIZING HELIOX

TECHNOLOGY UTILIZING HELIOX

Our devices are being developed to offer improvements/enhancements over conventional inhalers and nebulizers and are designed to effectuate the rapid and measured delivery of the desired pharmaceutical directly into targeted regions of the lung.

Pure Scientific Technologies intends to expand the use of Heliox beyond its current limited medical use to offer treatment for a wide variety of conditions.

APPLICATION OF HELIOX TODAY

  • During acute asthma exacerbations, albuterol nebulized with Heliox (Left) leads to more significant improvement in spirometry compared with albuterol nebulized with oxygen (Right) because the lower-density Heliox improves albuterol deposition in the distal airways.
  • FDA-approved breathing gas, non-toxic, non-carcinogenic with a history of decades of critical care use.
  • Comprised with Helium (He) and Oxygen (O₂) typically in a ratio of 80:20 or 70:30
  • Small helium atom makes Heliox less dense than pure oxygen and more easily absorbed by the lungs

THE “HELIOS” INHALATION DESIGN

1
2
3
4
HELIOS: PST HELIOX INHALER

The “HELIOS” series of inhalers incorporates smart technology for easy data collection of dosage, carrier gas flow and pressure, and other critical quality assurance requirements.  The system is designed to provide secure data and metrics to physicians and caregivers. 

Unique single dose cartridges are integral to the Heliox system and are scanned and recorded daily as part of a typical series of prescription doses for quality assurances purposes.